企業プロフィール
Centessa Pharmaceuticals 株価・ニュース・カタリスト
- ティッカー:
- CNTA
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United Kingdom
株価パフォーマンス
40.50 USD (+0.80%)
終値
最終更新: 2026年6月23日
6.17B USD
時価総額
株価変動の要因
Current closing-price context is not available for CNTA.
企業概要
事業概要
Centessa Pharmaceuticals is a platform biopharma company incubating focused therapeutic programs across multiple disease areas. Its model emphasizes capital allocation, program selection, and broad platform optionality.
所在地とセクター分類
Headquartered in the United Kingdom and listed on NASDAQ as an ADR, Centessa has a global specialty-biopharma profile.
ビジネスモデルの特徴
The company depends on pipeline prioritization, clinical validation, and the ability to unlock value from multiple programs.
バイオ業界での位置付け
Centessa is a platform biotech name whose valuation reflects optionality and execution across a portfolio of assets.
今後のカタリスト
- Centessa’s catalyst set is ORX750 and the broader orexin-agonist strategy, which could matter a lot if the sleep program continues to show a clean dose and efficacy profile. The next update is important because the market wants to know whether the orexin thesis can become a real franchise.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。